Clinical and histological events preceding hepatitis B e antigen seroconversion in chronic type B hepatitis. 1983

Y F Liaw, and C M Chu, and I J Su, and M J Huang, and D Y Lin, and C S Chang-Chien

A 60-mo longitudinal study has been undertaken in 99 HBeAg-positive patients with clinicopathologically verified chronic hepatitis. Hepatitis B e antigen clearance occurred in 30 patients at a rate of approximately 17% per year. A phenomenon of abrupt elevation of serum glutamic pyruvic transaminase (greater than 300 IU/L) with histological changes compatible with chronic lobular hepatitis was observed in 13 of 20 patients (65%) preceding spontaneous HBeAg clearance. In contrast, 8 of 10 patients on immunosuppressive or antiviral therapy, or both, had uneventful HBeAg clearance. It was concluded that HBeAg clearance can occur in patients with varying immunologic status. The mechanism responsible for HBeAg clearance awaits further study.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008137 Longitudinal Studies Studies in which variables relating to an individual or group of individuals are assessed over a period of time. Bogalusa Heart Study,California Teachers Study,Framingham Heart Study,Jackson Heart Study,Longitudinal Survey,Tuskegee Syphilis Study,Bogalusa Heart Studies,California Teachers Studies,Framingham Heart Studies,Heart Studies, Bogalusa,Heart Studies, Framingham,Heart Studies, Jackson,Heart Study, Bogalusa,Heart Study, Framingham,Heart Study, Jackson,Jackson Heart Studies,Longitudinal Study,Longitudinal Surveys,Studies, Bogalusa Heart,Studies, California Teachers,Studies, Jackson Heart,Studies, Longitudinal,Study, Bogalusa Heart,Study, California Teachers,Study, Longitudinal,Survey, Longitudinal,Surveys, Longitudinal,Syphilis Studies, Tuskegee,Syphilis Study, Tuskegee,Teachers Studies, California,Teachers Study, California,Tuskegee Syphilis Studies
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011239 Prednisolone A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states. Di-Adreson-F,Predate,Predonine,Di Adreson F,DiAdresonF
D005260 Female Females
D006509 Hepatitis B INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. Hepatitis B Virus Infection
D006510 Hepatitis B Antibodies Antibodies to the HEPATITIS B ANTIGENS, including antibodies to the surface (Australia) and core of the Dane particle and those to the "e" antigens. Anti-Australia Antigens,Anti-HBAg,Anti-Hepatitis B Antigens,Anti HBAg,Hepatitis B Virus Antibodies,Anti Australia Antigens,Anti Hepatitis B Antigens,Antibodies, Hepatitis B,Antigens, Anti-Australia,Antigens, Anti-Hepatitis B,B Antibodies, Hepatitis,B Antigens, Anti-Hepatitis,HBAg, Anti
D006511 Hepatitis B Antigens Antigens of the virion of the HEPATITIS B VIRUS or the Dane particle, its surface (HEPATITIS B SURFACE ANTIGENS), core (HEPATITIS B CORE ANTIGENS), and other associated antigens, including the HEPATITIS B E ANTIGENS. HBAg,Hepatitis B Antigen,Antigen, Hepatitis B,Antigens, Hepatitis B,B Antigen, Hepatitis,B Antigens, Hepatitis
D006513 Hepatitis B e Antigens A closely related group of antigens found in the plasma only during the infective phase of hepatitis B or in virulent chronic hepatitis B, probably indicating active virus replication; there are three subtypes which may exist in a complex with immunoglobulins G. HBeAg,Hepatitis B e Antigen,Hepatitis Be Antigen,e Antigen,e Antigens,HBe Ag-1,HBe Ag-2,Hepatitis Be Antigens,Antigen, Hepatitis Be,Antigen, e,Antigens, Hepatitis Be,Antigens, e,Be Antigen, Hepatitis,Be Antigens, Hepatitis

Related Publications

Y F Liaw, and C M Chu, and I J Su, and M J Huang, and D Y Lin, and C S Chang-Chien
November 1981, Annals of internal medicine,
Y F Liaw, and C M Chu, and I J Su, and M J Huang, and D Y Lin, and C S Chang-Chien
February 1999, Hepatology (Baltimore, Md.),
Y F Liaw, and C M Chu, and I J Su, and M J Huang, and D Y Lin, and C S Chang-Chien
June 1981, Annals of internal medicine,
Y F Liaw, and C M Chu, and I J Su, and M J Huang, and D Y Lin, and C S Chang-Chien
September 2003, Chinese medical journal,
Y F Liaw, and C M Chu, and I J Su, and M J Huang, and D Y Lin, and C S Chang-Chien
January 2010, Scandinavian journal of gastroenterology,
Y F Liaw, and C M Chu, and I J Su, and M J Huang, and D Y Lin, and C S Chang-Chien
October 2010, Digestive diseases and sciences,
Y F Liaw, and C M Chu, and I J Su, and M J Huang, and D Y Lin, and C S Chang-Chien
January 2018, Liver international : official journal of the International Association for the Study of the Liver,
Y F Liaw, and C M Chu, and I J Su, and M J Huang, and D Y Lin, and C S Chang-Chien
October 1997, The Journal of infectious diseases,
Y F Liaw, and C M Chu, and I J Su, and M J Huang, and D Y Lin, and C S Chang-Chien
August 1980, Gastroenterology,
Y F Liaw, and C M Chu, and I J Su, and M J Huang, and D Y Lin, and C S Chang-Chien
October 2021, World journal of gastroenterology,
Copied contents to your clipboard!